Work

Profiling the microbiota to develop innovative therapies for infectious diarrhea

Year: 2025
Type: dissertation
Study design: Observational Study
Abstract: Gastrointestinal pathogens such as Salmonella, Clostridioides difficile, Campylobacter, and Shigella are major causes of diarrhea and can significantly disrupt the gut microbiota composition. The intricate relationship between the microbiota, the host, and invading pathogens are complex. For example, fecal microbiota transplant (FMT) is the transfer of donor stool in patients, and is an effective treatment for recurrent C. difficile infections (rCDi). The success of FMT is often attributed to the restoration of the bacterial community in patients. Profiling the microbiota using next-generation sequencing techniques provides a powerful tool to assess compositional changes, offering insights into the dynamic interactions between the microbiota and disease. This thesis aims to evaluate the compositional changes in individuals with infectious diarrhea, with the ultimate goal of paving the way for innovative therapeutic applications. We hypothesize that the microbiota may play a protective role against symptomatic Salmonella infections. To investigate this, the virulence of Salmonella strains isolated from symptomatic and asymptomatic individuals was compared, in addition to their bacterial profiles and those of healthy controls. The comparable virulence of the strains suggest it does not influence the clinical outcome. Symptomatic individuals exhibited a reduced abundance of beneficial bacteria, presenting an opportunity for therapeutic intervention. Therefore, we propose a probiotic mix containing these beneficial bacteria, which may have potential in protecting against diarrhea. Next, we also evaluated the temporal changes in individuals infected with bacterial diarrhea, in addition to the impact of antibiotic treatment. Profiles before and after disease resolution were comparable irrespective of antibiotic treatment, questioning the necessity of antibiotic treatment in bacterial diarrhea. Then, we evaluated the potential of a novel fecal microbiota transplantation (FMT) formulation encapsulated in alginate as an alternative to the current standard-of-care frozen oral capsules. The alginate particles displayed a comparable bacterial profile to the capsules and maintained stability over 24 months. These microbeads offer potential for a more convenient treatment experience and easier storage at room temperature. Lastly, we characterized the phage profiles of rCDi patients who underwent FMT. We assessed the preservation of phages in frozen oral capsules and observed the engraftment of donor-derived phages after treatment, which remained stable over time. Before treatment, patients exhibited low viral diversity, which significantly increased following FMT. We report that FMT treatment at CHUV alters the phage composition in rCDi patients, potentially contributing to its efficacy. In conclusion, this thesis investigated the bacterial and phage communities in patients and formulations associated with infectious diarrhea. These findings enhance our understanding of the role of microbiota in infectious diarrhea and provide a foundation for developing innovative therapeutic strategies.
Source: IRIS
Author: Chen, Carmen
Language: English
Open Access status: green
OpenAlex ID: W7132897734
Cites: 606
Cited by:
Related to: 10